Is genetic testing to assess the risk of statin-induced myopathy commercially available?[Scroll to bottom for answer]
Yes. Commercial testing for SLCO1B1 variants is available. Although variants in this and other genes play a role in statin-myopathy, the clinical utility of such testing is unproven and is not recommended for routine use at the present time.